1
|
Merino-Goyenechea J, Palacios-Alberti J, Yanes-Martínez T, Martínez-Valladares M, Balaña-Fouce R. Treatment and Healing of Leishmaniasis in a Wolf in Semi-Captivity Regime from an Educational Center of Zamora Province (Spain). Animals (Basel) 2024; 14:1436. [PMID: 38791654 PMCID: PMC11117261 DOI: 10.3390/ani14101436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2024] [Revised: 05/06/2024] [Accepted: 05/08/2024] [Indexed: 05/26/2024] Open
Abstract
Leishmaniasis in wild canids is a vector-borne disease caused in Europe by the protozoan parasite Leishmania infantum. To date, there is limited information on clinical signs and laboratory abnormalities in wolves due to leishmaniasis. The current clinical case report described a female Iberian wolf (Canis lupus signatus) housed in semi-captivity conditions at the Centro del Lobo Ibérico "Félix Rodríguez de la Fuente", in Robledo de Sanabria, Zamora (Spain), with an interdigital ulcerous wound at the right forepaw, hyper-gammaglobulinemia, and abnormal liver blood parameters. Definitive serodiagnosis of leishmaniasis was established using antileishmanial serum antibodies and PCR analysis of different biological samples. A gold-standard anti-L. infantum treatment protocol consisting in subcutaneous meglumine antimoniate and oral allopurinol combination was installed. However, the presence of pain at the site of injection due to meglumine antimoniate administration forced its substitution by oral miltefosine. A progressive reduction of the levels of anti-L. infantum serum antibodies and the concentrations of gamma-globulin fraction was detected after antileishmanial treatment as well as a decline of liver GPT. To our knowledge, this is the first case of leishmaniasis diagnosed in a wolf housed in semi-captivity conditions, with the condition subsequently treated and successfully cured.
Collapse
Affiliation(s)
- Javier Merino-Goyenechea
- Departamento de Ciencias Biomédicas, Instituto de Biomedicina (IBIOMED), Facultad de Veterinaria, Universidad de León, Campus de Vegazana s/n., 24071 León, Spain;
- Centro del Lobo Ibérico “Félix Rodríguez de la Fuente” Robledo de Sanabria, Puebla de Sanabria, 49393 Zamora, Spain; (J.P.-A.); (T.Y.-M.)
| | - Jesús Palacios-Alberti
- Centro del Lobo Ibérico “Félix Rodríguez de la Fuente” Robledo de Sanabria, Puebla de Sanabria, 49393 Zamora, Spain; (J.P.-A.); (T.Y.-M.)
| | - Tomás Yanes-Martínez
- Centro del Lobo Ibérico “Félix Rodríguez de la Fuente” Robledo de Sanabria, Puebla de Sanabria, 49393 Zamora, Spain; (J.P.-A.); (T.Y.-M.)
| | - María Martínez-Valladares
- Instituto de Ganadería de Montaña (CSIC-Universidad de León), Finca Marzanas, Ctra. León-Grulleros s/n., Grulleros, 24346 León, Spain;
| | - Rafael Balaña-Fouce
- Departamento de Ciencias Biomédicas, Instituto de Biomedicina (IBIOMED), Facultad de Veterinaria, Universidad de León, Campus de Vegazana s/n., 24071 León, Spain;
| |
Collapse
|
2
|
Roura X, Cortadellas O, Day MJ, Benali SL, Zatelli A. Canine leishmaniosis and kidney disease: Q&A for an overall management in clinical practice. J Small Anim Pract 2020; 62:E1-E19. [PMID: 33107613 DOI: 10.1111/jsap.13237] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2020] [Accepted: 09/10/2020] [Indexed: 12/19/2022]
Affiliation(s)
- X Roura
- Hospital Clínic Veterinari, Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain
| | - O Cortadellas
- Hospital Clínico Veterinario, Universidad CEU Cardenal Herrera, 46115, Valencia, Spain
| | - M J Day
- School of Veterinary and Life Sciences, Murdoch University, 6150, Murdoch, Australia
| | - S L Benali
- Laboratorio La Vallonea, 20017, Milano, Italy
| | | | - A Zatelli
- Dipartimento di Medicina Veterinaria, Università degli Studi di Bari "Aldo Moro", 70010, Bari, Italy
| |
Collapse
|
3
|
Coyner KS, Ward JG. Pathology in Practice. J Am Vet Med Assoc 2020; 254:813-817. [PMID: 30888276 DOI: 10.2460/javma.254.7.813] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
4
|
Reguera RM, Morán M, Pérez-Pertejo Y, García-Estrada C, Balaña-Fouce R. Current status on prevention and treatment of canine leishmaniasis. Vet Parasitol 2016; 227:98-114. [PMID: 27523945 DOI: 10.1016/j.vetpar.2016.07.011] [Citation(s) in RCA: 72] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2015] [Revised: 07/07/2016] [Accepted: 07/08/2016] [Indexed: 01/17/2023]
Abstract
Canine leishmaniasis (CanL) is a parasite-borne disease mainly induced by Leishmania infantum in the Old World and Leishmania chagasi (infantum) in the New World. CanL is a zoonosis transmitted by the bite of infected Phlebotominae flies that act as vectors. CanL is a very serious disease that usually produces death when remains untreated and can be a focus of transmission to other dogs or humans. Infected dogs and other domestic and wild animals act as reservoirs and are a real threat to uninfected/healthy dogs and humans in endemic areas where the sand flies are present. Prevention of new infections in dogs can help to stop the current increase of the disease in humans, reinforcing the concept of "One Health" approach. The management of CanL is being performed using prophylactic measures in healthy dogs - insecticides impregnated in collars or immunostimulants applied by spot-on devices - and chemotherapy in animals that suffer from the disease. Antimonials as first-line monotherapy have proven efficacy in reducing most of the clinical signs of CanL, but they need to be administered during several days, and no complete parasite clearance is achieved, favouring the presence of relapses among treated dogs. Therefore, new drugs, such as miltefosine, or combinations of this drug or antimonials with allopurinol are in the pipeline of clinical treatment of CanL. Recently, there has been an emergence of protective - prophylactic - and curative - autogenous vaccines - immunotherapy tools to face CanL, whose results are still under study. This review highlights the current use of preventive and eradicative weapons to fight against this disease, which is a scourge for dogs and a continuous threat to human beings.
Collapse
Affiliation(s)
- Rosa M Reguera
- Departamento de Ciencias Biomédicas, Facultad de Veterinaria, Universidad de León, Campus de Vegazana s/n, 24071 León, Spain
| | - Miguel Morán
- Departamento de Ciencias Biomédicas, Facultad de Veterinaria, Universidad de León, Campus de Vegazana s/n, 24071 León, Spain
| | - Yolanda Pérez-Pertejo
- Departamento de Ciencias Biomédicas, Facultad de Veterinaria, Universidad de León, Campus de Vegazana s/n, 24071 León, Spain
| | - Carlos García-Estrada
- Departamento de Ciencias Biomédicas, Facultad de Veterinaria, Universidad de León, Campus de Vegazana s/n, 24071 León, Spain; Instituto de Biotecnología de León (INBIOTEC), Parque Científico de León, Avenida Real, n° 1, 24006 León, Spain
| | - Rafael Balaña-Fouce
- Departamento de Ciencias Biomédicas, Facultad de Veterinaria, Universidad de León, Campus de Vegazana s/n, 24071 León, Spain; Instituto de Biotecnología de León (INBIOTEC), Parque Científico de León, Avenida Real, n° 1, 24006 León, Spain.
| |
Collapse
|
5
|
Torres M, Pastor J, Roura X, Tabar MD, Espada Y, Font A, Balasch J, Planellas M. Adverse urinary effects of allopurinol in dogs with leishmaniasis. J Small Anim Pract 2016; 57:299-304. [DOI: 10.1111/jsap.12484] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2014] [Revised: 12/23/2015] [Accepted: 02/18/2016] [Indexed: 01/07/2023]
Affiliation(s)
- M. Torres
- Servei d'Urgències i Medecina Interna, Hospital Veterinari Balmes; Carrer Balmes 81 08008 Barcelona Spain
| | - J. Pastor
- Hospital Clínic Veterinari and Animal Medicine and Surgery Department, Faculty of Veterinary Medicine; Universitat Autònoma de Barcelona; Campus de la UAB, Plaza Cívica 08193 Bellaterra Spain
| | - X. Roura
- Hospital Clínic Veterinari and Animal Medicine and Surgery Department, Faculty of Veterinary Medicine; Universitat Autònoma de Barcelona; Campus de la UAB, Plaza Cívica 08193 Bellaterra Spain
| | - M. D. Tabar
- Servicio de Medicina Interna, Centro Policlínico Veterinario Raspeig, Calle Veterinario Manuel Isidro Rodríguez Rodriguez; 17, 03690, San Vicente del Raspeig Alicante Spain
| | - Y. Espada
- Hospital Clínic Veterinari and Animal Medicine and Surgery Department, Faculty of Veterinary Medicine; Universitat Autònoma de Barcelona; Campus de la UAB, Plaza Cívica 08193 Bellaterra Spain
| | - A. Font
- Servei de Medecina Interna, Hospital Ars Veterinària; Carrer Cardedeu 3 08023 Barcelona Spain
| | - J. Balasch
- Servei d'Urgències i Medecina Interna, Hospital Veterinari Balmes; Carrer Balmes 81 08008 Barcelona Spain
| | - M. Planellas
- Hospital Clínic Veterinari and Animal Medicine and Surgery Department, Faculty of Veterinary Medicine; Universitat Autònoma de Barcelona; Campus de la UAB, Plaza Cívica 08193 Bellaterra Spain
| |
Collapse
|
6
|
Beckwith-Cohen B, Gasper DJ, Bentley E, Gittelman H, Ellis AE, Snowden KF, Shock BC, Yabsley MJ, Dubielzig RR. Protozoal infections of the cornea and conjunctiva in dogs associated with chronic ocular surface disease and topical immunosuppression. Vet Ophthalmol 2015; 19:206-13. [DOI: 10.1111/vop.12285] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- Billie Beckwith-Cohen
- Comparative Ocular Pathology Laboratory of Wisconsin; School of Veterinary Medicine; the University of Wisconsin-Madison; Madison WI USA
| | - David J. Gasper
- Comparative Ocular Pathology Laboratory of Wisconsin; School of Veterinary Medicine; the University of Wisconsin-Madison; Madison WI USA
| | - Ellison Bentley
- Comparative Ocular Pathology Laboratory of Wisconsin; School of Veterinary Medicine; the University of Wisconsin-Madison; Madison WI USA
| | | | - Angela E. Ellis
- Athens Veterinary Diagnostic Laboratory; College of Veterinary Medicine; University of Georgia; Athens GA USA
| | - Karen F. Snowden
- College of Veterinary Medicine and Biomedical Sciences; Texas A&M University; College Station TX USA
| | - Barbara C. Shock
- Department of Pathology, Microbiology and Immunology; School of Veterinary Medicine; University of California Davis; Davis CA USA
| | - Michael J. Yabsley
- Department of Population Health; College of Veterinary Medicine; University of Georgia; Athens GA USA
| | - Richard R. Dubielzig
- Comparative Ocular Pathology Laboratory of Wisconsin; School of Veterinary Medicine; the University of Wisconsin-Madison; Madison WI USA
| |
Collapse
|
7
|
ROVIROSA-HERNÁNDEZ MARÍADEJESÚS, CORTES-ORTÍZ LILIANA, GARCÍA-ORDUÑA FRANCISCO, GUZMÁN-GÓMEZ DANIEL, LÓPEZ-MONTEON ARACELY, CABA MARIO, RAMOS-LIGONIO ANGEL. Seroprevalence ofTrypanosoma cruziandLeishmania mexicanain Free-Ranging Howler Monkeys in Southeastern Mexico. Am J Primatol 2012; 75:161-9. [DOI: 10.1002/ajp.22094] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2012] [Revised: 10/06/2012] [Accepted: 10/13/2012] [Indexed: 11/09/2022]
Affiliation(s)
| | - LILIANA CORTES-ORTÍZ
- Museum of Zoology Department of Ecology and Evolutionary Biology; University of Michigan; Ann Arbor; Michigan
| | | | | | | | - MARIO CABA
- Centro de Investigaciones Biomédicas; Universidad Veracruzana; Xalapa; Veracruz; México
| | | |
Collapse
|